Skip to main content
logo
Yoda Pharmaceuticals Inc. (TPEX:7829)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
46.40
+0.45 (0.98%)
At close: Sep 7, 2026

Yoda Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
4,6124,652---
Market Cap Growth
-15.81%----
Enterprise Value
3,5344,203---
Last Close Price
46.4058.60---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
4.334.73---
P/TBV Ratio
4.364.77---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
00.000.00-0.52
Net Debt / Equity Ratio
-1.01-0.33-0.99-0.99-0.56
Net Debt / EBITDA Ratio
2.820.832.823.730.23
Net Debt / FCF Ratio
3.410.923.284.090.23
Quick Ratio
32.7310.5935.6814.631.53
Current Ratio
32.8432.4235.9215.101.59
Return on Equity (ROE)
-48.22%-50.58%-39.96%-48.27%-
Return on Assets (ROA)
-30.44%-29.47%-27.66%-28.89%-
Return on Capital Employed (ROCE)
-35.90%-39.70%-35.40%-26.80%-254.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-7.89%-8.75%---
FCF Yield
-6.85%-7.61%---
Buyback Yield / Dilution
-22.80%-85.48%-258.46%-2.07%-